Effective as of May 4, 2023, the Board of Directors (the Board) of Talis Biomedical Corporation (the Company) appointed Ms. Kimberly Popovits, who has served as a member of the Board since March 2020, as Lead Independent Director of the Board in accordance with the Company's Amended and Restated Bylaws.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.9 USD | -1.11% | +2.30% | +19.46% |
May. 08 | Talis Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+19.46% | 16.4M | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- TLIS Stock
- News Talis Biomedical Corporation
- Talis Biomedical Corporation Appoints Kimberly Popovits as Lead Independent Director